Loading...
Development and Advanced Validation of an Optimized Method for the Quantitation of Aβ(42) in Human Cerebrospinal Fluid
Cerebrospinal fluid (CSF) biomarkers have been extensively utilized in the diagnosis of Alzheimer’s disease (AD) and characterization of progression. One important CSF biomarker is the amyloid beta 42 (Aβ(42)) peptide, a key player in AD pathogenesis. The INNOTEST® Aβ(42) ELISA kit has been widely u...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer US
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3385823/ https://ncbi.nlm.nih.gov/pubmed/22552903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-012-9360-7 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|